The Pharmaceuticals industry is undergoing massive change and challenge: finding and commercializing advances under stricter regulations; slowing pipelines; expiring patents; generic, importation, counterfeit and global competition; emerging markets; outsourcing; pricing, reimbursement and safety issues; and convergence with biotech and medical device industries.
Sutherland began providing legal support to this industry more than thirty years ago. Today we’re one of the top U.S. law firms serving pharmaceutical companies, helping many of the world’s largest companies as they produce next-generation drugs through genetics, biologics, biochemicals, proteomics and more. We are actively engaged in generic paragraph IV patent opinions and litigations. Many of our lawyers draw from their life sciences graduate degrees, using in-depth knowledge that’s especially critical in protecting discoveries. We also provide business advice for company formation and financing; mergers, acquisitions, joint ventures and licensing; transactions; tax; litigation; and more.
© 2010 Sutherland Asbill & Brennan LLP